Atomic structure of a thermostable subdomain of HIV-1 gp41
- PMID: 9356444
- PMCID: PMC24915
- DOI: 10.1073/pnas.94.23.12303
Atomic structure of a thermostable subdomain of HIV-1 gp41
Abstract
Infection by HIV-1 involves the fusion of viral and cellular membranes with subsequent transfer of viral genetic material into the cell. The HIV-1 envelope glycoprotein that mediates fusion consists of the surface subunit gp120 and the transmembrane subunit gp41. gp120 directs virion attachment to the cell-surface receptors, and gp41 then promotes viral-cell membrane fusion. A soluble, alpha-helical, trimeric complex within gp41 composed of N-terminal and C-terminal extraviral segments has been proposed to represent the core of the fusion-active conformation of the HIV-1 envelope. A thermostable subdomain denoted N34(L6)C28 can be formed by the N-34 and C-28 peptides connected by a flexible linker in place of the disulfide-bonded loop region. Three-dimensional structure of N34(L6)C28 reveals that three molecules fold into a six-stranded helical bundle. Three N-terminal helices within the bundle form a central, parallel, trimeric coiled coil, whereas three C-terminal helices pack in the reverse direction into three hydrophobic grooves on the surface of the N-terminal trimer. This thermostable subdomain displays the salient features of the core structure of the isolated gp41 subunit and thus provides a possible target for therapeutics designed selectively to block HIV-1 entry.
Figures




Similar articles
-
Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion.J Virol. 1999 May;73(5):4433-8. doi: 10.1128/JVI.73.5.4433-4438.1999. J Virol. 1999. PMID: 10196341 Free PMC article.
-
Core structure of gp41 from the HIV envelope glycoprotein.Cell. 1997 Apr 18;89(2):263-73. doi: 10.1016/s0092-8674(00)80205-6. Cell. 1997. PMID: 9108481
-
Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.Biochemistry. 2000 Feb 22;39(7):1634-42. doi: 10.1021/bi9921687. Biochemistry. 2000. PMID: 10677212
-
Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.Eur J Med Chem. 2011 Apr;46(4):979-92. doi: 10.1016/j.ejmech.2011.01.046. Epub 2011 Feb 3. Eur J Med Chem. 2011. PMID: 21345545 Review.
-
Peptide and non-peptide HIV fusion inhibitors.Curr Pharm Des. 2002;8(8):563-80. doi: 10.2174/1381612024607180. Curr Pharm Des. 2002. PMID: 11945159 Review.
Cited by
-
Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer.Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12438-43. doi: 10.1073/pnas.1307382110. Epub 2013 Jun 11. Proc Natl Acad Sci U S A. 2013. PMID: 23757493 Free PMC article.
-
Constrained peptides as miniature protein structures.ISRN Biochem. 2012 Sep 26;2012:692190. doi: 10.5402/2012/692190. eCollection 2012. ISRN Biochem. 2012. PMID: 25969758 Free PMC article. Review.
-
gp41: HIV's shy protein.Nat Med. 2004 Feb;10(2):133-4. doi: 10.1038/nm0204-133. Nat Med. 2004. PMID: 14760422 Free PMC article.
-
Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.J Biol Chem. 2006 Apr 28;281(17):11965-71. doi: 10.1074/jbc.M601174200. Epub 2006 Feb 28. J Biol Chem. 2006. PMID: 16507566 Free PMC article.
-
Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides.J Biol Chem. 2010 Aug 13;285(33):25506-15. doi: 10.1074/jbc.M110.101170. Epub 2010 Jun 10. J Biol Chem. 2010. PMID: 20538590 Free PMC article.
References
-
- Luciw P A. In: Fields Virology. Fields B N, Knipe D M, Howley P M, Chanock R M, Melinick J L, Monath T P, Roizman B, Straus S E, editors. Philadelphia: Lippincott; 1996. pp. 1881–1952.
-
- Nara P L, Garrity R R, Goudsmit J. FASEB J. 1991;5:2437–2455. - PubMed
-
- Freed E Q, Martin M A. J Biol Chem. 1995;270:23883–23886. - PubMed
-
- Wilkinson D. Curr Biol. 1996;6:1051–1053. - PubMed
-
- Wiley D C, Skehel J J. Annu Rev Biochem. 1987;56:365–394. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources